anonymous
Guest
anonymous
Guest
I'm not drinking the coolaid... but, I'm sold Ramona!
I'm not drinking the coolaid... but, I'm sold Ramona!
If you'd like to know what we have been discussing in Deerfield it involves this: When we combine primary care how many Shire v Takeda do we cut. ZS is helping with that. Shire's CNS team will stay. EVERYONE on Takeda's will go. GI specialty will be combined and cut. $65 Billion is a lot of money. We need to cut drastically to ensure the remaining employees future. It's going to be ugly, but the survivors will be happy.
If you'd like to know what we have been discussing in Deerfield it involves this: When we combine primary care how many Shire v Takeda do we cut. ZS is helping with that. Shire's CNS team will stay. EVERYONE on Takeda's will go. GI specialty will be combined and cut. $65 Billion is a lot of money. We need to cut drastically to ensure the remaining employees future. It's going to be ugly, but the survivors will be happy.
Really this one is a stretch. Shire’s GI Specialty team is tiny, new drugs coming and SubQ launch I just can’t see this playing out. As for the CNS side probably cut in half with the new combined team will be half and half.
Not a stretch at all. This integration will see many many Takeda people cut as Takeda had to promise to keep many Shire people in place as part of the deal. This also is the easiest time to get rid of a bunch of sales people under the guise of the merger. Shire has a market cap twice that of Takeda. If you think they are simply being acquired with a whimper, you are living in a dream world. Get your resume ready and get moving.